Understanding the Stages of Multiple System Atrophy (MSA)

Understanding the Stages of Multiple System Atrophy (MSA)

Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder affecting several brain regions, resulting in symptoms related to movement, autonomic function, and sleep.
Here's how the progression of MSA can be understood:

Initial (Early) Stage:
  • Symptoms include autonomic dysfunctions like orthostatic hypotension (dizziness or fainting when standing), constipation, urinary problems (incontinence or retention), and sexual dysfunction.
  • Mild parkinsonian symptoms might start appearing, including rigidity and bradykinesia (slow movement).
  • For cerebellar type (MSA-C), balance issues and uncoordinated movements might be evident.
  • Daily activities are still manageable with some adaptations, but diagnosis can be tricky due to similarity with other conditions.

Intermediate Stage:
  • Autonomic symptoms become more severe, with more frequent issues with blood pressure possibly needing treatment.
  • Motor symptoms progress, with increased rigidity, slower movements, and possible tremors. Speech and swallowing difficulties emerge.
  • Sleep disorders like REM sleep behavior disorder become noticeable or worsen.
  • Mobility might require aids like canes or walkers. Daily life becomes more challenging, with a higher dependency on caregivers.

Advanced (Late) Stage:
  • Autonomic failure is profound, with severe blood pressure fluctuations, temperature regulation issues, and significant urinary and bowel problems.
  • Motor impairment is extreme; individuals might be wheelchair-bound or bedridden with a loss of voluntary movement.
  • Speech is severely impaired, making it difficult or impossible to communicate without aids.
  • Cognitive or psychiatric symptoms might develop.
  • The focus shifts to comfort, palliative care, and end-of-life planning.

Note on Staging:
  • MSA's progression isn't universally staged like some diseases, with variability among individuals.
  • Life expectancy post-diagnosis averages 6 to 10 years, influenced by various factors including MSA subtype and overall health.

Conclusion:
  • Recognizing these stages aids in planning care, setting realistic expectations, and managing the disease's effects.
  • Early diagnosis and symptom management can improve quality of life.
  • Research continues to aim for better symptom control and possibly slowing or stopping disease progression.
  • Awareness and education about MSA are crucial for enhanced patient care and research advancement.
    Back to blog

    Leave a public comment:

    Please note, comments need to be approved before they are published.

    • Introducing Your Guide to Atypical Parkinsonism Care: A Lifeline for Caregivers

      Introducing Your Guide to Atypical Parkinsonism...

      We’re thrilled to announce the release of Your Guide to Atypical Parkinsonism Care: Understanding and Supporting Loved Ones with PSP, MSA, CBD, and DLB, a vital new resource for anyone...

      Introducing Your Guide to Atypical Parkinsonism...

      We’re thrilled to announce the release of Your Guide to Atypical Parkinsonism Care: Understanding and Supporting Loved Ones with PSP, MSA, CBD, and DLB, a vital new resource for anyone...

    • Understanding Caregiver Burnout and Atypical Parkinsonism: Finding Relief Through Respite and Vacation Grants

      Understanding Caregiver Burnout and Atypical Pa...

      Caring for a loved one with atypical parkinsonism—conditions like Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), or Corticobasal Degeneration (CBD)—is a labor of love that often comes with immense...

      Understanding Caregiver Burnout and Atypical Pa...

      Caring for a loved one with atypical parkinsonism—conditions like Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), or Corticobasal Degeneration (CBD)—is a labor of love that often comes with immense...

    • Introducing the CCF Awareness Shop for Atypical Parkinsonism: Wear It, Share It, Support It

      Introducing the CCF Awareness Shop for Atypical...

      We’re excited to unveil the CCF Coleen Cunningham Foundation Awareness Shop—a new way to raise awareness for atypical parkinsonism and support our mission at the same time! At CCF, we’re...

      Introducing the CCF Awareness Shop for Atypical...

      We’re excited to unveil the CCF Coleen Cunningham Foundation Awareness Shop—a new way to raise awareness for atypical parkinsonism and support our mission at the same time! At CCF, we’re...

    • The Ustep Walker: A Game-Changer for Atypical Parkinsonism

      The Ustep Walker: A Game-Changer for Atypical P...

        The Ustep walker is a specialized mobility aid designed to support individuals with neurological conditions, including atypical Parkinsonism. Unlike standard walkers, the Ustep is engineered with features that address...

      The Ustep Walker: A Game-Changer for Atypical P...

        The Ustep walker is a specialized mobility aid designed to support individuals with neurological conditions, including atypical Parkinsonism. Unlike standard walkers, the Ustep is engineered with features that address...

    1 of 4